SEC Form 4 · accession 0001128732-18-000006
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director
Period of report
Jun 20, 2018
Accepted (ET)
Jun 28, 2018 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | A | 27,000,000 | $0.001 | A | 79,384,373 | D |
Table II — derivative securities
No Table II lines on this filing.